Stoke Therapeutics, Inc. Common Stock (NASDAQ: STOK) last traded at $32.29, up 2.83% on the session. The quote above updates while this page is open; the figures below are drawn from Stoke Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Stoke Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker STOK. Its market capitalisation is $2.08 billion.
Valuation measures for Stoke Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $2.08B |
|---|---|
| Enterprise value | $2.02B |
| Price / sales | 75.52 |
| Price / book | 6.03 |
| Beta | 0.85 |
Trailing-twelve-month figures tagged in Stoke Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $27.59M |
|---|---|
| Net income (TTM) | -$207.90M |
| EPS (TTM) | -$3.34 |
| Operating margin | -809.69% |
| Return on equity | -60.17% |
| Cash | $110.00M |
Range and volume for STOK over the past 52 weeks.
| 52-week high | $40.22 |
|---|---|
| 52-week low | $18.00 |
| Volume | 885.9K |
| Average volume | 833.2K |
| Previous close | $31.40 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.